Jason Raleigh Nunn
Director · Addex Therapeutics Ltd.
IndividualBuying only
- 2025
- Sep 4, 2026
- 3
Other insiders active in the same sector
No other insider has filed at Jason Raleigh Nunn's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- WARBURG PINCUS CO. - $1.12B in SHC purchases and sales in the last 12 months
- CP Circle ML Holdco GP, LLC - $1.07B in MDLN purchases and sales in the last 12 months
- TC Group Cayman Investment Holdings, L.P. - $1.07B in MDLN purchases and sales in the last 12 months
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- TPG GP A, LLC - $742.97M in LFST purchases and sales in the last 12 months
- GTCR INVESTMENT XI LLC - $639.50M in SHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Raleigh Nunn?
Jason Raleigh Nunn is a corporate insider, tracked as Director of Addex Therapeutics Ltd. (ADXN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason Raleigh Nunn submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jason Raleigh Nunn been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1.20M) and 0 open-market sales across all tracked filings.
